SEC halts trading in stock of LV company

Monday, July 26, 1999 | 11:50 a.m.

The Securities and Exchange Commission suspended trading in the stock of Uniprime Capital Acceptance Inc., a Las Vegas company that claims to have developed a cure for AIDS.

New Technologies & Concepts Inc., a Uniprime subsidiary, last week issued a news release saying AIDS patients treated with its Plasma Plus formula in Spain showed "complete reversal of the HIV virus with virtually no side effects!"

The SEC said it suspended the over-the-counter trading of Uniprime securities on Thursday and that the suspension is scheduled to terminate on Aug. 5.

The SEC cited "concerns that there was a lack of current and accurate information regarding the accuracy and adequacy of" information released by Uniprime.

Uniprime officials could not be reached for comment.

archive